Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-23 Option Award |
2024-02-27 5:02 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director |
3,886 | $0 | 87,943 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:01 pm |
N/A 2034-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director |
13,621 | $0 | 97,678 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 5:01 pm |
N/A 2033-02-23 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director |
10,179 | $0 | 94,236 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 5:16 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director |
3,882 | $0 | 84,057 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:26 pm |
2023-02-22 2032-02-22 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director |
10,729 | $0 | 90,904 (Direct) |
View |
| 2022-02-19 Option Award |
2022-02-23 4:15 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director |
4,222 | $0 | 80,175 (Direct) |
View |
| 2021-08-11 Exercise |
2021-08-12 4:32 pm |
N/A N/A |
SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director |
15,000 | $12.98 | 75,953 (Direct) |
View |
| 2021-08-11 Exercise |
2021-08-12 4:32 pm |
2017-03-01 2026-03-01 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director |
15,000 | $0 | 75,953 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-23 6:49 pm |
2022-02-19 2031-02-19 |
SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director |
11,587 | $0 | 72,540 (Direct) |
View |